Home · Research · Members · Publications · Contact

We study virus-driven immune remodeling after HSCT and CAR-T and develop immunotherapies in acute leukemia to improve immune recovery and disease control.
By integrating HSCT, CAR-T, and other immune-based strategies, we aim to advance precision treatment for hematologic malignancies.